Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	11	15	12	11	15	31
Market Cap Growth	-18.75%	20.00%	7.14%	-26.32%	-49.89%	-
Enterprise Value	-6	-1	23	21	25	38
Last Close Price	0.07	0.09	0.07	0.07	0.10	0.19
PE Ratio	0.81	1.00	1.65	-	3.03	-
PS Ratio	22.21	30.75	32.95	21.98	2.41	4.21
PB Ratio	0.51	0.70	1.93	1.70	1.39	5.61
P/TBV Ratio	0.51	0.70	1.93	-	-	-
P/FCF Ratio	-	-	-	5.43	7.89	11.34
P/OCF Ratio	-	-	-	5.43	7.68	10.99
EV/Sales Ratio	-	-	62.12	40.45	3.90	5.26
EV/EBITDA Ratio	-	-	-	-	22.64	21.88
EV/EBIT Ratio	-	-	-	-	25.15	23.75
EV/FCF Ratio	-	-	-	9.99	12.80	14.15
Debt / Equity Ratio	0.01	0.01	0.30	1.09	0.76	0.95
Debt / EBITDA Ratio	-	-	-	-	7.31	2.88
Debt / FCF Ratio	-	-	-	3.48	4.31	1.92
Net Debt / Equity Ratio	-0.81	-0.81	-0.95	0.89	0.53	0.65
Net Debt / EBITDA Ratio	12.13	12.13	2.78	-4.19	5.26	2.03
Net Debt / FCF Ratio	14.62	14.62	2.29	2.85	2.98	1.31
Asset Turnover	0.03	0.03	0.02	0.02	0.29	0.34
Quick Ratio	6.39	6.39	2.21	0.24	0.91	0.41
Current Ratio	6.57	6.57	2.72	0.26	0.92	0.42
Return on Equity (ROE)	96.67%	96.67%	-70.32%	-68.98%	70.57%	-343.40%
Return on Assets (ROA)	-5.13%	-5.13%	-8.18%	-4.23%	2.78%	4.75%
Return on Invested Capital (ROIC)	-51.62%	-67.57%	-34.23%	-10.50%	7.65%	15.08%
Return on Capital Employed (ROCE)	-6.90%	-6.90%	-27.80%	-13.20%	5.20%	12.70%
Earnings Yield	138.92%	100.33%	60.75%	-41.98%	32.98%	-50.26%
FCF Yield	-10.96%	-7.92%	-21.53%	18.42%	12.67%	8.82%
Buyback Yield / Dilution	-	-	-	-0.07%	-48.07%	-41.06%